Diabetes Mellitus, Type 1 Clinical Trials in Boston, Massachusetts

7 studies are recruiting for diabetes mellitus, type 1 in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes

   This study will evaluate the safety, tolerability and efficacy of VX-880 infusion and VX-017 infusion in participants with type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.

   Stage

   Phase 3

   Ages

   18 to 65

   Site

   Massachusetts General Hospital, Boston, Massachusetts

   Locations

   29 in total

   Run by

   Vertex Pharmaceuticals Incorporated

   See if you can join NCT04786262 on ClinicalTrials.gov

2. Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

   Minoritized individuals with type 1 diabetes (T1D) have approximately 2% higher average A1c levels and twice the rate of hospitalizations, complications, and mortality as their white counterparts. However, the efficacy trials establishing the benefits of hybrid closed loop (HCL) pump therapy in T1D…

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Boston Medical Center, Boston, Massachusetts

   Locations

   2 in total

   Run by

   Boston Medical Center

   See if you can join NCT06236607 on ClinicalTrials.gov

3. Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

   Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Whether these drugs have similar effects in patients with type 1 diabetes (T1D) remains unknown because …

   Stage

   Phase 3

   Ages

   18 to 75

   Site

   Joslin Diabetes Center, Boston, Massachusetts

   Locations

   19 in total

   Run by

   Alessandro Doria

   See if you can join NCT06217302 on ClinicalTrials.gov

4. TrialNet Pathway to Prevention of T1D

   Rationale: The accrual of data from the laboratory and from epidemiologic and prevention trials has improved the understanding of the etiology and pathogenesis of type 1 diabetes mellitus (T1DM). Genetic and immunologic factors play a key role in the development of T1DM, and characterization of the…

   Stage

   Not phased

   Ages

   2 to 45

   Site

   Joslin Diabetes Center, Boston, Massachusetts

   Locations

   22 in total

   Run by

   University of South Florida

   See if you can join NCT00097292 on ClinicalTrials.gov

5. Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes

   The goal of this clinical trial is to test the effects of a ketogenic diet on the progression and control of type 1 diabetes in children with newly diagnosed diabetes. The main questions to answer are: * Does a ketogenic diet prolong the honeymoon period of type 1 diabetes? * Does a ketogenic diet …

   Stage

   Not phased

   Ages

   5 to 12

   Site

   Boston Children's Hospital, Boston, Massachusetts

   Run by

   Boston Children's Hospital

   See if you can join NCT05899166 on ClinicalTrials.gov

6. Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes

   The overall goal of the study is to create a standardized, stakeholder-informed system within EMRs, that will enable an equitable and regular prescription and documentation of advanced diabetes technologies. This will reduce racial disparities and generate an understanding of the reasons behind pre…

   Stage

   Not phased

   Ages

   2 to 95

   Site

   T1D Exchange, Boston, Massachusetts

   Locations

   2 in total

   Run by

   T1D Exchange, United States

   See if you can join NCT06931275 on ClinicalTrials.gov

7. The T1D Exchange Registry

   The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity…

   Stage

   Not phased

   Ages

   Any age

   Site

   T1D Exchange, Boston, Massachusetts

   Run by

   T1D Exchange, United States

   See if you can join NCT04629586 on ClinicalTrials.gov